Comparing Eden and Hers? Discover how Eden connects individuals to licensed providers for personalized GLP-1-based care with support tools built in.
Looking for care designed around your needs?
Eden helps you connect with licensed providers who can guide your next steps with a personalized approach.
GLP-1 receptor agonists like semaglutide (Wegovy®) and liraglutide (Saxenda®) are reshaping how licensed medical providers support metabolic health and chronic weight management. While originally developed to regulate blood sugar, these medications are now FDA-approved for weight management in certain individuals with obesity or those who are overweight with related health conditions such as type 2 diabetes or high blood pressure.
Two digital health platforms, Eden and Hers, connect individuals to licensed providers who may determine whether a GLP-1 medication is appropriate. While both offer telehealth access, their approaches to personalization, provider engagement, and ongoing support differ.
Considering GLP-1 treatment?
Connect with a licensed medical provider who can evaluate your eligibility and discuss the best treatment options for your needs.
GLP-1 receptor agonists such as semaglutide (Wegovy®) and liraglutide are approved for:
These medications mimic the GLP-1 hormone, which helps regulate appetite, glucose levels, and insulin secretion. They are part of a medical treatment plan, not a standalone solution. Their use should be guided by a licensed provider based on a full clinical evaluation and the patient’s health history.
Eden is a digital health platform that helps individuals connect with independent, licensed medical providers who evaluate whether certain treatments, including GLP-1 medications, may be appropriate based on a person’s health profile and goals. Eden does not practice medicine, prescribe medications, or operate as a pharmacy.
Through Eden, users are guided through a secure intake process that is submitted to a licensed medical provider working independently of Eden. That provider conducts a clinical review to determine whether a GLP-1-based treatment plan, such as with semaglutide, liraglutide, or tirzepatide, may be appropriate. Any decisions about prescribing medication are made solely by the provider based on their professional judgment and the individual’s health history.
While Eden is not involved in clinical care, the platform offers a suite of digital tools that may help individuals stay organized and engaged throughout their health journey. These may include:
These resources are designed to complement, not replace, the treatment plan and guidance provided by the medical provider.
If a licensed provider prescribes a medication, the prescription is sent to an independent state-licensed compounding pharmacy, which handles all medication preparation and delivery. Eden is not a pharmacy and does not produce, compound, or dispense medications.
Ready to explore your GLP-1 treatment options?
Talk to a licensed provider and learn whether GLP-1 medications are appropriate for you.
Hers is a telehealth brand that offers access to various health and wellness services, including mental health, dermatology, and weight management. Its GLP-1 program is centered around fast and simple access to semaglutide.
The Hers intake process is designed for speed. Individuals complete an online consultation and, if approved, receive a prescription for semaglutide. This approach may be appealing for those looking for rapid access without ongoing check-ins or a long-term plan.
Hers offers semaglutide-based treatment; however, it is unclear whether providers offer alternatives such as liraglutide or tirzepatide. The program is primarily designed to facilitate access to GLP-1 prescriptions, with limited emphasis on ongoing clinical engagement or lifestyle support.
Hers offers limited tools for behavior change or lifestyle support. The model is not designed for continuous clinical oversight or flexible medication planning.
When choosing between Eden and Hers, consider the following:
Hers may suit individuals looking for fast access to semaglutide with minimal interaction, but Eden offers long-term care planning and provider follow-up.
Eden gives you access to licensed providers who can tailor treatment and follow-up based on your evolving needs. This includes dose flexibility, a broader range of medication options, and integrated lifestyle tools.
If your goal is sustainable metabolic health, Eden’s structured model may be better suited. The platform helps members build behaviors that support their outcomes over time.
Want a care experience built around your goals?
Take the first step with Eden and connect with a provider who understands your needs.
Choosing a GLP-1 program is about more than just accessing medication. It’s about understanding your health goals, evaluating your support needs, and selecting a platform that aligns with your desired experience.
Eden connects members with independent, licensed medical providers who review each individual's health information to assess eligibility for treatment. If appropriate, a provider may prescribe a GLP-1 medication, such as semaglutide, liraglutide, or tirzepatide, and may offer a treatment plan that includes follow-up care and recommendations to support long-term wellness.
For those seeking long-term support, medical oversight, and tools for sustainable metabolic improvement, Eden offers a thoughtful, provider-led experience. Hers, while convenient, may suit those looking for a medication-first, minimal-interaction model.
Either way, your journey to metabolic health starts with a conversation with a licensed provider who can help determine the most appropriate path for you.
This content is for informational purposes only and does not constitute medical advice. Eden does not compound, manufacture, or prescribe medications. Eden connects members with independent licensed healthcare providers and state-licensed pharmacies, who independently determine treatment plans. Always consult a qualified healthcare professional before beginning or changing any treatment.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
